Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
14 results
D3.166 - Attention-deficit/hyperactivity disorder (ADHD) in asthmatic children
D3.168 - Clinical Department of Allergy Center in Linköping
D3.169 - Paediatric Severe Acute Respiratory Infections in Malta: A Three-Year Review
D3.171 - Validation of the Kazakh Version of the Asthma Quality of Life Questionnaire (AQLQ) for Clinical Use in Adult Patients with Asthma
D3.173 - Switching from Dupilumab to Tezepelumab in a Child with Severe Asthma and Atopic Dermatitis: Clinical Considerations and Therapeutic Implications
D3.174 - Short-term tolerance of omlyclo, the omalizumab biosimilar
D3.175 - Algorithm for Biologics Selection in Severe Asthma
D3.178 - Assessment of blood rheological properties in children with bronchial asthma
D3.179 - Longitudinal breath profiling of exhaled volatile organic compounds differentiates viral-induced asthma exacerbation from clinical control
- D3.540 - Sources of IL-13 in Acute Versus Chronic Models of Eosinophilic Esophagitis
- D3.538 - Aeroallergen sensitisation as a risk factor for paediatric eosinophilic esophagitis
- D3.539 - Evaluation of Treatment Selection and Response in Patients with Eosinophilic Esophagitis Based on Clinical Findings and Allergy Testing
- D3.541 - Who takes the patient with eosinophilic esophagitis (EoE) and acute laryngeal edema?
- D3.542 - Prevalence of sensitization to panallergens and IgG4 profiles against specific foods in patients with allergic-phenotype eosinophilic esophagitis
Download the app
The congress at your fingertips
Available on
Download